Isodiol International Inc. is the market leader in pharmaceutical grade phytochemical compounds and the industry leader in the manufacturing and development of consumer products. We have pioneered many firsts for the cannabis industry, including commercialization of 99%+ pure, pharmaceutical grade cannabinoids, micro-encapsulations, and nanotechnology for the highest quality consumable and topical skin care products and most recently received approval as having the first CBD designated as an Active Pharmaceutical Ingredient as was announced April 26, 2018. Our growth strategy includes the development of over-the-counter and pharmaceutical drugs, expanding our phytoceutical portfolio and we will continue to aggressively expand internationally into Latin America, Asia and Europe. A Publicly Traded Company::Trade Symbol: ISOLF